Ketamine One Capital and Cognetivity Neurosciences have entered into a partnership to study and develop assessments for depression and post-traumatic stress disorder (PTSD).
Awakn has signed a Memorandum of Understanding (MOU) with the Devon Partnership NHS Trust and the University of Exeter to increase access to psychedelic-assisted therapy for...
A study undertaken over a five-year period has shown that a single dose of ketamine improved thinking and reasoning in people who had expressed thoughts of...
The findings from a Phase II A/B study, which is the world’s first study on ketamine-assisted psychotherapy for alcohol use disorder, will be published in the...
The first ketamine clinic in the UK has received approval from the Care Quality Commission (CQC) to begin treatments.
Currently, there is no cure for Parkinson’s Disease, however, certain medications can help improve symtoms.
Results from a recent study have demonstrated a significant reduction in depressive symptoms and suicidality using ketamine as a solo treatment.
Psychiatrist Dr Tiago Reis Marques discusses what new research findings on ketamine mean for treatment-resistant mental conditions such as major depressive disorder.
Atai Life Sciences and Introspect Digital Therapeutics will be testing a novel, digital therapeutic approach for patients using ketamine for treatment resistant depression.
People will now be able to participate in psychedelic-assisted therapy in a group setting as the Institute for Integrative Therapies expands its services to support the...